Tender

GOSH - NHS GMS Alliance ctDNA national transformation project Health Economics

GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST

This public procurement record has 2 releases in its history.

Tender

03 Jan 2023 at 10:22

Tender Notice
Tender

03 Jan 2023 at 10:03

Tender Notice
Summary of the contracting process

The Great Ormond Street Hospital for Children NHS Foundation Trust has initiated a tender titled "GOSH - NHS GMS Alliance ctDNA national transformation project Health Economics" within the Research laboratory services industry category. The procurement method being used is an Open procedure (below threshold), with a contract period starting on March 1, 2023, and ending on December 31, 2023. The tender's value is £150,000, with a tender period deadline set for January 20, 2023, at 12:00:00 UTC. The project involves exploring ctDNA testing for suspected stage 3/4 non-small cell lung cancer patients in London, United Kingdom.

This tender from Great Ormond Street Hospital for Children NHS Foundation Trust presents an opportunity for small and medium-sized enterprises (SMEs) and voluntary, community and social enterprise (VCSE) organisations to engage in a health economics evaluation project related to liquid biopsy testing. Businesses in the healthcare or laboratory services sectors with an interest in genomic testing and cancer research would be well-suited to compete for this tender and contribute to the evidence base for the further roll out of ctDNA testing in the NHS.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

GOSH - NHS GMS Alliance ctDNA national transformation project Health Economics

Notice Description

The NHS Genomic Medicine Service infrastructure, including the seven Genomic Laboratory Hubs (GLHs), enable the full repertoire of genomics testing for cancer patients in the NHS in England as outlined in the National Genomic Test Directory (Test Directory). Most of the somatic cancer testing in the Test Directory is based on testing the genetic make-up of an individual's tumour. This requires a tumour sample to be taken and then sent to the GLHs for testing. Increasingly it is becoming possible to use blood samples to test the circulating free DNA (cfDNA) for the presence of disease-causing mutations in circulating tumour DNA (ctDNA), also known as liquid biopsy testing. ctDNA based testing has now been validated, pan-cancer, in a number of different trials including I-SPY2, FLAUAS, AURA3, SCRUM-Japan, GOZILA, GRECO, MYSTIC, PEGASUS, COBRA, SOLAR1 and plasmaMATCH. ctDNA testing for EGFR gene mutations is already included on the Test Directory for lung cancer patients. To build the evidence base for the further roll out of ctDNA testing in the NHS, NHS England convened a group of experts to scope a project to explore ctDNA starting with suspected stage 3/4 non-small cell lung cancer patients. ctDNA samples will be taken from at least 700 patients with suspected thoracic malignancy without a confirmed histological diagnosis of stage 3/4 non-small cell lung cancer for direct gene panel analysis for those genes already approved on the Test Directory. ctDNA samples taken prior to the start of this project for patients with non-small cell lung cancer taken at the same time as tissue biopsy or after histological verification in parallel to tissue molecular analyses will also be included in this health economics evaluation. Numbers to be confirmed. We publish all our opportunities on the Health Family eCommercial System https://health-family.force.com/s/Welcome

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-3c9302c0-a391-4936-a6ff-604924b9cbb1
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/f42177c1-154a-4a45-b595-e8ae42dad6c3
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Not specified
Procurement Method
Open
Procurement Method Details
Open procedure (below threshold)
Tender Suitability
SME, VCSE
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

73 - Research and development services and related consultancy services

CPV Codes

73111000 - Research laboratory services

Notice Value(s)

Tender Value
£150,000 £100K-£500K
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
3 Jan 20233 years ago
Submission Deadline
20 Jan 2023Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
1 Mar 2023 - 31 Dec 2023 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 4BY
Post Town
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI44 Lewisham and Southwark
Delivery Location
TLI London
Local Authority
Southwark
Electoral Ward
Chaucer
Westminster Constituency
Bermondsey and Old Southwark

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-3c9302c0-a391-4936-a6ff-604924b9cbb1-2023-01-03T10:22:25Z",
    "date": "2023-01-03T10:22:25Z",
    "ocid": "ocds-b5fd17-3c9302c0-a391-4936-a6ff-604924b9cbb1",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "CF-1253000D0O000000rwimUAA",
        "title": "GOSH - NHS GMS Alliance ctDNA national transformation project Health Economics",
        "description": "The NHS Genomic Medicine Service infrastructure, including the seven Genomic Laboratory Hubs (GLHs), enable the full repertoire of genomics testing for cancer patients in the NHS in England as outlined in the National Genomic Test Directory (Test Directory). Most of the somatic cancer testing in the Test Directory is based on testing the genetic make-up of an individual's tumour. This requires a tumour sample to be taken and then sent to the GLHs for testing. Increasingly it is becoming possible to use blood samples to test the circulating free DNA (cfDNA) for the presence of disease-causing mutations in circulating tumour DNA (ctDNA), also known as liquid biopsy testing. ctDNA based testing has now been validated, pan-cancer, in a number of different trials including I-SPY2, FLAUAS, AURA3, SCRUM-Japan, GOZILA, GRECO, MYSTIC, PEGASUS, COBRA, SOLAR1 and plasmaMATCH. ctDNA testing for EGFR gene mutations is already included on the Test Directory for lung cancer patients. To build the evidence base for the further roll out of ctDNA testing in the NHS, NHS England convened a group of experts to scope a project to explore ctDNA starting with suspected stage 3/4 non-small cell lung cancer patients. ctDNA samples will be taken from at least 700 patients with suspected thoracic malignancy without a confirmed histological diagnosis of stage 3/4 non-small cell lung cancer for direct gene panel analysis for those genes already approved on the Test Directory. ctDNA samples taken prior to the start of this project for patients with non-small cell lung cancer taken at the same time as tissue biopsy or after histological verification in parallel to tissue molecular analyses will also be included in this health economics evaluation. Numbers to be confirmed. We publish all our opportunities on the Health Family eCommercial System https://health-family.force.com/s/Welcome",
        "datePublished": "2023-01-03T10:03:19Z",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "73111000",
            "description": "Research laboratory services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "postalCode": "WC1N 3JH"
                    },
                    {
                        "region": "London",
                        "countryName": "United Kingdom"
                    },
                    {
                        "postalCode": "WC1N 3JH"
                    },
                    {
                        "region": "London",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 150000,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure (below threshold)",
        "tenderPeriod": {
            "endDate": "2023-01-20T12:00:00Z"
        },
        "contractPeriod": {
            "startDate": "2023-03-01T00:00:00Z",
            "endDate": "2023-12-31T23:59:59Z"
        },
        "suitability": {
            "sme": true,
            "vcse": true
        },
        "documents": [
            {
                "id": "1",
                "documentType": "tenderNotice",
                "description": "Opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/e006bf3e-4d91-4f8c-8de7-a4e79fed6c43",
                "datePublished": "2023-01-03T10:03:19Z",
                "format": "text/html",
                "language": "en"
            },
            {
                "id": "2",
                "documentType": "tenderNotice",
                "description": "Opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/f42177c1-154a-4a45-b595-e8ae42dad6c3",
                "datePublished": "2023-01-03T10:03:19Z",
                "dateModified": "2023-01-03T10:22:25Z",
                "format": "text/html",
                "language": "en"
            }
        ]
    },
    "parties": [
        {
            "id": "GB-CFS-197160",
            "name": "Great Ormond Street Hospital for Children NHS Foundation Trust",
            "identifier": {
                "legalName": "Great Ormond Street Hospital for Children NHS Foundation Trust"
            },
            "address": {
                "streetAddress": "200 Great Dover Street",
                "locality": "London",
                "postalCode": "SE1 4BY",
                "countryName": "GB"
            },
            "contactPoint": {
                "name": "Mart Somerville",
                "email": "mark.somerville@gstt.nhs.uk"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-197160",
        "name": "Great Ormond Street Hospital for Children NHS Foundation Trust"
    }
}